Intuitive Surgical, Inc. (NASDAQ:ISRG) Holdings Trimmed by Trust Investment Advisors

Trust Investment Advisors cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 458 shares of the medical equipment provider’s stock after selling 29 shares during the quarter. Trust Investment Advisors’ holdings in Intuitive Surgical were worth $239,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of ISRG. Atala Financial Inc bought a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $25,000. Berbice Capital Management LLC acquired a new position in Intuitive Surgical in the fourth quarter worth approximately $26,000. BankPlus Trust Department bought a new position in shares of Intuitive Surgical in the fourth quarter valued at $28,000. Kohmann Bosshard Financial Services LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter valued at $31,000. Finally, Decker Retirement Planning Inc. bought a new stake in shares of Intuitive Surgical during the 4th quarter worth $36,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Brian Edward Miller sold 8,900 shares of the company’s stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the sale, the executive vice president now owns 5,758 shares of the company’s stock, valued at $2,793,033.06. This represents a 60.72 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Jamie Samath sold 269 shares of Intuitive Surgical stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the completion of the transaction, the chief financial officer now directly owns 3,282 shares in the company, valued at approximately $1,936,380. This represents a 7.58 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock valued at $17,691,621 over the last three months. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Trading Up 2.2 %

Intuitive Surgical stock opened at $519.81 on Wednesday. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The firm’s fifty day simple moving average is $561.24 and its 200-day simple moving average is $532.59. The company has a market capitalization of $185.15 billion, a P/E ratio of 81.09, a P/E/G ratio of 5.85 and a beta of 1.43.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on ISRG shares. Jefferies Financial Group upped their target price on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Royal Bank of Canada raised their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. BTIG Research boosted their price target on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. JPMorgan Chase & Co. upped their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Finally, Erste Group Bank cut shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 17th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.